-
1
-
-
7044229778
-
Primary liver cancer: Worldwide incidence and trends
-
DOI 10.1053/j.gastro.2004.09.011, PII S0016508504015902
-
Bosch FX, Ribes J, Diaz M, Cleries R,. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-16. (Pubitemid 39423365)
-
(2004)
Gastroenterology
, vol.127
, Issue.SUPPL.
-
-
Bosch, F.X.1
Ribes, J.2
Diaz, M.3
Cleries, R.4
-
2
-
-
0023224738
-
Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival
-
DOI 10.1002/1097-0142(19870 615)59:12<2108::AID-CNCR282 0591225>3.0.CO;2-3
-
Attali P, Prod'Homme S, Pelletier G, et al,. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer 1987; 59: 2108-11. (Pubitemid 17077799)
-
(1987)
Cancer
, vol.59
, Issue.12
, pp. 2108-2111
-
-
Attali, P.1
Prod'Homme, S.2
Pelletier, G.3
-
3
-
-
62749123476
-
Prognostic indicators in hepatocellular carcinoma: A systematic review of 72 studies
-
Tandon P, Garcia-Tsao G,. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009; 29: 502-10.
-
(2009)
Liver Int
, vol.29
, pp. 502-510
-
-
Tandon, P.1
Garcia-Tsao, G.2
-
4
-
-
16244369103
-
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
-
DOI 10.1002/hep.20636
-
Marrero JA, Fontana RJ, Barrat A, et al,. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16. (Pubitemid 40462931)
-
(2005)
Hepatology
, vol.41
, Issue.4
, pp. 707-716
-
-
Marrero, J.A.1
Fontana, R.J.2
Barrat, A.3
Askari, F.4
Conjeevaram, H.S.5
Su, G.L.6
Lok, A.S.7
-
5
-
-
77954016931
-
Selecting an optimal staging system for Hepatocellular carcinoma: Comparison of 5 currently used prognostic models
-
Hsu CY, Huang YH, Su CW, et al,. Selecting an optimal staging system for Hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer 2010; 116: 3006-14.
-
(2010)
Cancer
, vol.116
, pp. 3006-3014
-
-
Hsu, C.Y.1
Huang, Y.H.2
Su, C.W.3
-
6
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
DOI 10.1056/NEJM199603143341104
-
Mazzaferro V, Regalia E, Doci R, et al,. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9. (Pubitemid 26079803)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.11
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
Montalto, F.7
Ammatuna, M.8
Morabito, A.9
Gennari, L.10
-
7
-
-
80053267175
-
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement
-
Prasad KR, Young RS, Burra P, et al,. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 2011; 17: S81-9.
-
(2011)
Liver Transpl
, vol.17
-
-
Prasad, K.R.1
Young, R.S.2
Burra, P.3
-
8
-
-
40549119470
-
Liver transplantation for hepatocellular carcinoma
-
Mazzaferro V, Chun YS, Poon RT, et al,. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008; 15: 1001-7.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 1001-1007
-
-
Mazzaferro, V.1
Chun, Y.S.2
Poon, R.T.3
-
9
-
-
0037897745
-
Review article: Liver transplantation for hepatocellular carcinoma
-
Steinmuller T, Jonas S, Neuhaus P,. Review article: liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17: 138-44. (Pubitemid 36831471)
-
(2003)
Alimentary Pharmacology and Therapeutics, Supplement
, vol.17
, Issue.2
, pp. 138-144
-
-
Steinmuller, T.1
Jonas, S.2
Neuhaus, P.3
-
10
-
-
84859902982
-
Systematic review: The role of liver transplantation in the management of hepatocellular carcinoma
-
Maggs JR, Suddle AR, Aluvihare V, Heneghan MA,. Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 1113-34.
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 1113-1134
-
-
Maggs, J.R.1
Suddle, A.R.2
Aluvihare, V.3
Heneghan, M.A.4
-
11
-
-
0034856294
-
Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference
-
DOI 10.1016/S0168-8278(01)00130-1, PII S0168827801001301
-
Bruix J, Sherman M, Llovet JM, et al,. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30. (Pubitemid 32844200)
-
(2001)
Journal of Hepatology
, vol.35
, Issue.3
, pp. 421-430
-
-
Bruix, J.1
Sherman, M.2
Llovet, J.M.3
Beaugrand, M.4
Lencioni, R.5
Burroughs, A.K.6
Christensen, E.7
Pagliaro, L.8
Colombo, M.9
Rodes, J.10
-
12
-
-
28844480321
-
Management of hepatocellular carcinoma
-
DOI 10.1002/hep.20933
-
Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. (Pubitemid 43112690)
-
(2005)
Hepatology
, vol.42
, Issue.5
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
13
-
-
0036829556
-
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
-
DOI 10.1053/jhep.2002.36780
-
Hassan MM, Hwang LY, Hatten CJ, et al,. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-13. (Pubitemid 35253437)
-
(2002)
Hepatology
, vol.36
, Issue.5
, pp. 1206-1213
-
-
Hassan, M.M.1
Hwang, L.-Y.2
Hatten, C.J.3
Swaim, M.4
Li, D.5
Abbruzzese, J.L.6
Beasley, P.7
Patt, Y.Z.8
-
14
-
-
77955850168
-
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
-
Gines P, Angeli P, Lenz K, et al,. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
-
(2010)
J Hepatol
, vol.53
, pp. 397-417
-
-
Gines, P.1
Angeli, P.2
Lenz, K.3
-
15
-
-
0037223652
-
Model for end-stage liver disease (MELD) and allocation of donor livers
-
DOI 10.1053/gast.2003.50016
-
Wiesner R, Edwards E, Freeman R, et al,. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6. (Pubitemid 36055342)
-
(2003)
Gastroenterology
, vol.124
, Issue.1
, pp. 91-96
-
-
Wiesner, R.1
Edwards, E.2
Freeman, R.3
Harper, A.4
Kim, R.5
Kamath, P.6
Kremers, W.7
Lake, J.8
Howard, T.9
Merion, R.M.10
Wolfe, R.A.11
Krom, R.12
Colombani, P.M.13
Cottingham, P.C.14
Dunn, S.P.15
Fung, J.J.16
Hanto, D.W.17
McDiarmid, S.V.18
Rabkin, J.M.19
Teperman, L.W.20
Turcotte, J.G.21
Wegman, L.R.22
more..
-
16
-
-
77953120359
-
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring System
-
Hsu CY, Huang YH, Hsia CY, et al,. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 2010; 53: 108-17.
-
(2010)
J Hepatol
, vol.53
, pp. 108-117
-
-
Hsu, C.Y.1
Huang, Y.H.2
Hsia, C.Y.3
-
17
-
-
33745320148
-
The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
-
Huo TI, Lin HC, Huang YH, et al,. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 2006; 107: 141-8.
-
(2006)
Cancer
, vol.107
, pp. 141-148
-
-
Huo, T.I.1
Lin, H.C.2
Huang, Y.H.3
-
18
-
-
33646541682
-
Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy
-
Huo TI, Huang YH, Lin HC, et al,. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 2006; 101: 975-82.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 975-982
-
-
Huo, T.I.1
Huang, Y.H.2
Lin, H.C.3
-
19
-
-
84858658381
-
EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma
-
The European Association for the Study of the Liver; The European Organisation for Research and Treatment of Cancer.
-
The European Association for the Study of the Liver; The European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43.
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
20
-
-
17244381293
-
Percutaneous ablation therapy for hepatocellular carcinoma: Current practice and future perspectives
-
Huo TI, Huang YH, Wu JC,. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc 2005; 68: 155-9.
-
(2005)
J Chin Med Assoc
, vol.68
, pp. 155-159
-
-
Huo, T.I.1
Huang, Y.H.2
Wu, J.C.3
-
21
-
-
33745684425
-
Treatment and prognostic factors in patients with hepatocellular carcinoma
-
DOI 10.1111/j.1478-3231.2006.001285.x
-
Martins A, Cortez-Pinto H, Marques-Vidal P, et al,. Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int 2006; 26: 680-7. (Pubitemid 43994787)
-
(2006)
Liver International
, vol.26
, Issue.6
, pp. 680-687
-
-
Martins, A.S.M.1
Cortez-Pinto, H.2
Marques-Vidal, P.3
Mendes, N.4
Silva, S.5
Fatela, N.6
Gloria, H.7
Marinho, R.8
Tavora, I.9
Ramalho, F.10
Carneiro De Moura, M.11
-
22
-
-
84875705928
-
Systematic review: The prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma
-
Hakeem AR, Young RS, Marangoni G, Lodge JPA, Prasad KR,. Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 987-99.
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 987-999
-
-
Hakeem, A.R.1
Young, R.S.2
Marangoni, G.3
Lodge, J.P.A.4
Prasad, K.R.5
-
23
-
-
79959372785
-
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
-
Cabibbo G, Genco C, Di Marco V, et al,. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther 2011; 34: 196-204.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 196-204
-
-
Cabibbo, G.1
Genco, C.2
Di Marco, V.3
-
24
-
-
0036189111
-
Prognostic prediction and treatment strategy in hepatocellular carcinoma
-
DOI 10.1053/jhep.2002.32089
-
Bruix J, Llovet JM,. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24. (Pubitemid 34183954)
-
(2002)
Hepatology
, vol.35
, Issue.3
, pp. 519-524
-
-
Bruix, J.1
Llovet, J.M.2
-
25
-
-
80051545416
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
-
D'Avola D, Inarrairaegui M, Pardo F, et al,. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. Ann Surg Oncol 2011; 18: 1964-71.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 1964-1971
-
-
D'Avola, D.1
Inarrairaegui, M.2
Pardo, F.3
-
26
-
-
74049149294
-
Review article: The management of hepatocellular carcinoma
-
Cabrera R, Nelson DR,. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 31: 461-76.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 461-476
-
-
Cabrera, R.1
Nelson, D.R.2
-
27
-
-
80052342926
-
Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: A systematic review
-
Cho YK, Rhim H, Noh S,. Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol 2011; 26: 1354-60.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 1354-1360
-
-
Cho, Y.K.1
Rhim, H.2
Noh, S.3
-
28
-
-
84855955803
-
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
-
Wang JH, Wang CC, Hung CH, Chen CL, Lu SN,. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012; 56: 412-8.
-
(2012)
J Hepatol
, vol.56
, pp. 412-418
-
-
Wang, J.H.1
Wang, C.C.2
Hung, C.H.3
Chen, C.L.4
Lu, S.N.5
-
29
-
-
84455173830
-
Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
-
Nishikawa H, Inuzuka T, Takeda H, et al,. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011; 11: 143.
-
(2011)
BMC Gastroenterol
, vol.11
, pp. 143
-
-
Nishikawa, H.1
Inuzuka, T.2
Takeda, H.3
-
30
-
-
79955062942
-
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis
-
Hsu CY, Huang YH, Chiou YY, et al,. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Liver Transpl 2011; 17: 556-66.
-
(2011)
Liver Transpl
, vol.17
, pp. 556-566
-
-
Hsu, C.Y.1
Huang, Y.H.2
Chiou, Y.Y.3
-
31
-
-
0033037745
-
Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: An analysis of survival in 419 patients
-
Huang YH, Wu JC, Chau GY, et al,. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999; 11: 315-21.
-
(1999)
Eur J Gastroenterol Hepatol
, vol.11
, pp. 315-321
-
-
Huang, Y.H.1
Wu, J.C.2
Chau, G.Y.3
-
32
-
-
77955671299
-
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma
-
Dhanasekaran R, Khanna V, Kooby DA, et al,. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21: 1197-204.
-
(2010)
J Vasc Interv Radiol
, vol.21
, pp. 1197-1204
-
-
Dhanasekaran, R.1
Khanna, V.2
Kooby, D.A.3
-
33
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
-
DOI 10.1016/S0140-6736(02)08649-X
-
Llovet JM, Real MI, Montana X, et al,. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9. (Pubitemid 34607087)
-
(2002)
Lancet
, vol.359
, Issue.9319
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montana, X.3
Planas, R.4
Coll, S.5
Aponte, J.6
Ayuso, C.7
Sala, M.8
Muchart, J.9
Sola, R.10
Rodes, J.11
Bruix, J.12
-
34
-
-
74049091234
-
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma
-
Giannini EG, Bodini G, Corbo M, et al,. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 31: 493-501.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 493-501
-
-
Giannini, E.G.1
Bodini, G.2
Corbo, M.3
|